Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.68% | $19.01M | €333.89B | 41.34% | 76 Outperform | |
| AstraZeneca | 1.85% | $13.11M | £209.78B | 37.08% | 76 Outperform | |
| Nestlé SA | 1.74% | $12.39M | CHF202.97B | 11.94% | 71 Outperform | |
| Roche Holding AG | 1.70% | $12.04M | CHF229.33B | 26.96% | 73 Outperform | |
| Novartis AG | 1.69% | $12.03M | CHF198.73B | 15.96% | 80 Outperform | |
| HSBC Holdings | 1.69% | $11.97M | £189.68B | 50.23% | 79 Outperform | |
| SAP SE | 1.67% | $11.88M | €246.38B | -5.08% | 66 Neutral | |
| Shell (UK) | 1.48% | $10.48M | £164.08B | 10.39% | 77 Outperform | |
| Siemens | 1.35% | $9.57M | €180.41B | 21.28% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.25% | $8.90M | €316.65B | 6.57% | 78 Outperform |